543 Results for "

PKC

" in MedChemExpress (MCE) Product Catalog:
Products (543)

543 Results for "PKC" in MCE Product Catalog:

  • Targets Recommended:
  • Recombinant Proteins Recommended:
6
6 Cited Publications
Cat. No.: HY-B0719
CAS No.: 75567-37-2
Synonyms: Ingenol 3-angelate; PEP005
Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-α, PKC-β, PKC-γ, PKC-δ, and PKC-ε, respectively, and has antiinflammatory and antitumor activity.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P0154
CAS No.: 182683-50-7
Synonyms: ε-V1-2; EAVSLKPT
Target:  

PKC

Research Areas:  

Inflammation/Immunology

Epsilon-V1-2 (ε-V1-2), a PKCε-derived peptide, is a selective PKCε inhibitor. Epsilon-V1-2 inhibits the translocationof PKCε, but not α-, β-, and δPKC .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-117800
CAS No.: 1564249-38-2
Purity:  99.85%
Synonyms: B106
Target:  

PKC Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

BJE6-106 (B106) is a potent, selective 3 rd generation PKCδ inhibitor with an IC50 of 0.05 μM and targets selectivity over classical PKC isozyme PKCα (IC50=50 μM). BJE6-106 (B106) induces caspase-dependent apoptosis. BJE6-106 (B106) possesses tumor-specific effect.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-113308A
CAS No.: 6042-32-6
Purity:  99.81%
Taurolithocholic acid sodium salt is an orally active bile acid and antiviral agent. Taurolithocholic acid sodium salt upregulates FADS2 by activating the TGR5-PI3K/AKT-SREBP2 signaling axis, inhibits SFTSV-induced ferroptosis, viral replication and viral entry of HBV/HDV, while reducing the release of IL-1β, lipid ROS and LDH. While exerting antiviral protective effects, Taurolithocholic acid sodium salt also stimulates the recycling of hepatocellular membrane transporters, impairs canalicular bile acid secretion function, and induces hepatocyte cholestasis, apoptosis and acute hepatocellular injury. Taurolithocholic acid sodium salt serves as an experimental model compound for hepatocellular cholestasis. At concentrations ≤200 μM, Taurolithocholic acid sodium salt shows no cytotoxicity and does not activate the interferon pathway. Taurolithocholic acid sodium salt not only protects mice from lethal SFTSV infection but also is suitable for studies related to severe fever with thrombocytopenia syndrome and cholestasis .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-101047
CAS No.: 123-78-4
Purity:  ≥98.0%
Synonyms: Erythrosphingosine; erythro-C18-Sphingosine; trans-4-Sphingenine
D-erythro-Sphingosine (Erythrosphingosine) is a very potent activator of p32-kinase with an EC50 of 8 μM, and inhibits protein kinase C (PKC). D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-100932
CAS No.: 105637-50-1
Purity:  99.86%
Target:  

Myosin

Research Areas:  

Cancer

ML-9 is a selective and potent inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK) and stromal interaction molecule 1 (STIM1) activity . ML-9 inhibits inhibits MLCK, PKA and PKC activity with Ki values of 4, 32 and 54 μM, respectively . ML-9 induces autophagy by stimulating autophagosome formation and inhibiting their degradation .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-18271
CAS No.: 1208123-85-6
Target:  

CaMK

Research Areas:  

Neurological Disease

CaMKII-IN-1 is a highly selective inhibitor of CaMKII with an IC50 value of 63nM. It has almost no effect on CaMKIV, MLCK, p38a, Akt1, and PKC.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-107407
CAS No.: 135897-06-2
Purity:  98.30%
Research Areas:  

Cancer

SB-218078 is a potent, selective, ATP-competitive and cell-permeable checkpoint kinase 1 (Chk1) inhibitor that inhibits Chk1 phosphorylation of cdc25C with an IC50 of 15 nM. SB-218078 is less potently inhibits Cdc2 (IC50 of 250 nM) and PKC (IC50 of 1000 nM). SB-218078 causes apoptosis by DNA damage and cell cycle arrest .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-107421
CAS No.: 60857-08-1
Purity:  99.80%
Prostratin, a natural terpenoid compound, is a PKC activator, with a Ki of 12.5 nM and shows inhibitory effect on HIV-1.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-101569
CAS No.: 1874276-76-2
Purity:  99.42%
Synonyms: LXS196; IDE196
Target:  

PKC

Research Areas:  

Cancer

Darovasertib (LXS196) is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. Darovasertib has the potential for uveal melanoma research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-107207
CAS No.: 32602-81-6
Purity:  99.68%
Synonyms: Kaempferol 3-O-neohesperidoside
Kaempferol 3-neohesperidoside (Kaempferol 3-O-neohesperidoside) is a flavonoid. Kaempferol 3-neohesperidoside mimics insulin action via the PI3K/PKC pathway, significantly promoting glucose uptake and increasing muscle glycogen content in rat soleus muscles. Kaempferol 3-neohesperidoside also exhibits anti-glycation activity. Kaempferol 3-neohesperidoside binds to albumin through hydrogen bonding and hydrophobic interactions, and inhibits the formation of advanced glycation end products. Kaempferol 3-neohesperidoside can be used in studies of diabetes and its related complications .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-18985
CAS No.: 37558-16-0
Synonyms: Phorbol dibutyrate; PDBu
Target:  

PKC

Research Areas:  

Cancer

Phorbol 12,13-dibutyrate (Phorbol dibutyrate) is a PKC activator and a potent skin tumor promoter .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12598A
CAS No.: 146255-66-5
Purity:  99.65%
Synonyms: (RS)-3,5-DHPG
Target:  

mGluR

Research Areas:  

Neurological Disease

DHPG is the agonist for mGluR 1/5 (EC50 for mGluR 1 is 60 nM) that activates the phospholipase C (PLC) pathway, and leads ultimately to the activation of protein kinase C (PKC) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-123979
CAS No.: 3316-02-7
Purity:  95.05%
Synonyms: NSC37044
Target:  

PKC Apoptosis

Research Areas:  

Cancer

ζ-Stat (NSC37044) is a specific and atypical PKC-ζ inhibitor, with an IC50 of 5 μM. ζ-Stat can reduce melanoma cell lines proliferation and induce apoptosis, and has antitumor activity in vitro .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-123979A
CAS No.: 31894-34-5
Purity:  ≥97.0%
Synonyms: NSC37044 trisodium
Target:  

PKC Apoptosis

Research Areas:  

Cancer

ζ-Stat trisodium (NSC37044 trisodium) is a specific and atypical PKC-ζ inhibitor, with an IC50 of 5 μM. ζ-Stat trisodium can reduce melanoma cell lines proliferation and induce apoptosis, and has antitumor activity in vitro .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N0152
CAS No.: 17912-87-7
Myricitrin, a naturally occurring flavonoid, is an orally active nitric oxide (NO) and PKC inhibitor. Myricitrin has central nervous system activity, including anxiolytic-like action. Myricitrin possesses antioxidant, anti-inflammatory, antifibrotic and anti-malarial effects .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-B1029
CAS No.: 17230-88-5
Target:  

PKC Apoptosis Tyrosinase

Research Areas:  

Endocrinology Cancer

Danazol inhibits the proliferation of cancer cell MDA-MB-231 and MCF-7 with IC50 of 65 µg/mL and 31 µg/mL. Danazol arrests the cell cycle at G1 phase, induces apoptosis in MDA-MB-231 through PKCα signaling pathway .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-126477
CAS No.: 64091-91-4
Purity:  99.98%
NNK is a nicotine-nitrosated derivative. NNK simultaneously stimulates Bcl2 phosphorylation exclusively at Ser 70 and c-Myc at Thr 58 and Ser 62 through activation of both ERK1/2 and PKCα . NNK induces survival and proliferation of human lung cancer cells. NNK can be used for lung cancer mice model structure .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-103045
CAS No.: 865608-11-3
Purity:  98.95%
CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1 μM , 2.3 μM, 1.4 μM and 8.1 μM, respectively. CMPD101 can be used for the study of heart failure .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N0699
CAS No.: 2034-69-7
Synonyms: Dephnoretin; Thymelol
Daphnoretin (Dephnoretin; Thymelol) is a protein kinase C (PKC) activator that inhibits the expression of hepatitis B virus (HBV) surface antigen (HBsAg) and exhibits antiviral activity. Daphnoretin exerts its antitumor effects by inhibiting the activation of the PI3K/AKT signaling pathway and triggers the mitochondrial apoptosis pathway. Daphnoretin alleviates chondrocyte apoptosis and inflammatory responses by inhibiting endoplasmic reticulum stress and activation of the NLRP3 inflammasome. Daphnoretin regulates the differentiation and maturation of dendritic cells, inhibits their immunostimulatory function by downregulating the phosphorylation level of JNK, and thus exerts a protective effect in skin graft rejection .
loading...
    loading...